Magnesium pemoline and dextroamphetamine: a controlled study in children with minimal brain dysfunction.
D000704:Analysis of Variance; D001007:Anxiety; D001288:Attention / Q000187:drug effects; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002648:Child; D003913:Dextroamphetamine / Q000009:adverse effects / Q000627:therapeutic use*; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D006801:Humans; D006948:Hyperkinesis; D008274:Magnesium; D008297:Male; D010389:Pemoline / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011581:Psychological Tests; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D012919:Social Behavior
D010919:Placebos; D010389:Pemoline; D008274:Magnesium; D003913:Dextroamphetamine